Prescription Required
It is not known whether it is safe to consume alcohol with Intifyrex-Taj 2mg/ml Injection. Please consult your doctor.
Intifyrex-Taj 2mg/ml Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby however, there are limited human studies.
Intifyrex-Taj 2mg/ml Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Not relevant, as Intifyrex-Taj 2mg/ml Injection is intended for use in hospitalised patients.
Intifyrex-Taj 2mg/ml Injection should be used with caution in patients with kidney disease. Dose adjustment of Intifyrex-Taj 2mg/ml Injection may be needed. Please consult your doctor.<BR>Use of Intifyrex-Taj 2mg/ml Injection is not recommended in patients with severe kidney disease.
There is limited information available on the use of Intifyrex-Taj 2mg/ml Injection in patients with liver disease. Please consult your doctor.<BR>Use of Intifyrex-Taj 2mg/ml Injection is not recommended in patients with severe liver disease.
Eptifibatide is an antiplatelet medication that inhibits the aggregation of platelets by blocking the glycoprotein IIb/IIIa receptor. This prevents clot formation, especially during heart procedures like angioplasty.
Acute Coronary Syndrome (ACS): A group of conditions caused by reduced blood flow to the heart, including unstable angina and some types of heart attacks. Percutaneous Coronary Intervention (PCI): A procedure to open blocked coronary arteries, where this injection is used to prevent blood clots.
MBA in Pharmaceutical
Content Updated on
Sunday, 24 November, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA